Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.
about
Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancerATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation.Clinical Proteomics: Liquid Chromatography-Mass Spectrometry (LC-MS) Purification Systems.Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor.
P2860
Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization of the Tyrosi ...... ILAC) Quantitative Proteomics.
@ast
Characterization of the Tyrosi ...... ILAC) Quantitative Proteomics.
@en
type
label
Characterization of the Tyrosi ...... ILAC) Quantitative Proteomics.
@ast
Characterization of the Tyrosi ...... ILAC) Quantitative Proteomics.
@en
prefLabel
Characterization of the Tyrosi ...... ILAC) Quantitative Proteomics.
@ast
Characterization of the Tyrosi ...... ILAC) Quantitative Proteomics.
@en
P2093
P2860
P356
P1476
Characterization of the Tyrosi ...... SILAC) Quantitative Proteomics
@en
P2093
Arnhild Grothey
Justin Stebbing
Nicos Angelopoulos
P2860
P304
P356
10.1074/MCP.M115.048090
P577
2015-06-18T00:00:00Z